Krishna Institute of Medical Sciences Limited has informed the Exchange about Transcript
KIMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
KIMS Hospitals reported Q4 FY'26 revenue of INR 1,084 crore (up 35.3% YoY) but EBITDA margin contracted to 19.9% from 25.3% in Q4 FY'25. FY'26 PAT declined 37% to INR 242 crore due to heavy expansion costs. The company opened 8-9 new hospitals in FY'26 including facilities in Hyderabad (Kompally), Maharashtra (Thane, Sangli), Bangalore (Mahadevapuram, Electronic City), and Kerala (Kollam). New unit losses dragged EBITDA by INR 128 crore for the full year, while mature units maintained ~29% EBITDA margin. Management flagged insurance empanelment delays as the main bottleneck for new hospital ramp-up. A QIP of INR 1,500 crore is planned primarily to retire debt (currently ~INR 3,000 crore) and target a net debt/EBITDA ratio of 1:2.
The margin compression is concerning but appears temporary as new hospitals mature and insurance empanelments complete. The QIP will reduce leverage risk but will be EPS dilutive. Investors should monitor EBITDA loss trajectory from new units and Kondapur relocation costs in FY'27.